V Muthukumar1, A J Vanisree1. 1. Department of Biochemistry, University of Madras, Chennai - 600 025, INDIA.
Abstract
BACKGROUND: Neuroblastoma (NB) is a childhood cancer causing significant mortality in at least 1% children worldwide. NB is an embryonically derived tumor. The causative agents include genetic predisposition and dysregulated signaling cascades. Survivin is an important anti-apoptotic protein that is significantly up-regulated in NB. In this study, a naturally occurring ligand - Piperine was assessed for its interaction with Survivin protein. PURPOSE: The study was undertaken in order to identify the experimental feasibility of Survivin inhibitor ligand Piperine as targeting treatment of NB. METHODS: Protein sequences were retrieved and saved in PDB format. Similarly, the ligand data was processed using MGL (Molecular Graphics Laboratory) and chimera tools and saved in PDB format. Both protein and the ligand data were then uploaded to the docking server and docking parameters were set. RESULTS: In-silico docking study of a protein ligand interaction resulted in -3.36 Kcal/mol free energy value for the ligand, with an involvement of 1 hydrogen bond, 7 hydrophobic interactions and 13 ionic interactions. The results were correlated with the existing free energy value of > -3 Kcal/mol which is established for a good inhibitor. CONCLUSION: The molecular docking study for mice Survivin and Piperine shows good inhibitory interaction effect and can, therefore, be considered as a molecule against Survivin enhanced tumor condition including NB.
BACKGROUND:Neuroblastoma (NB) is a childhood cancer causing significant mortality in at least 1% children worldwide. NB is an embryonically derived tumor. The causative agents include genetic predisposition and dysregulated signaling cascades. Survivin is an important anti-apoptotic protein that is significantly up-regulated in NB. In this study, a naturally occurring ligand - Piperine was assessed for its interaction with Survivin protein. PURPOSE: The study was undertaken in order to identify the experimental feasibility of Survivin inhibitor ligand Piperine as targeting treatment of NB. METHODS: Protein sequences were retrieved and saved in PDB format. Similarly, the ligand data was processed using MGL (Molecular Graphics Laboratory) and chimera tools and saved in PDB format. Both protein and the ligand data were then uploaded to the docking server and docking parameters were set. RESULTS: In-silico docking study of a protein ligand interaction resulted in -3.36 Kcal/mol free energy value for the ligand, with an involvement of 1 hydrogen bond, 7 hydrophobic interactions and 13 ionic interactions. The results were correlated with the existing free energy value of > -3 Kcal/mol which is established for a good inhibitor. CONCLUSION: The molecular docking study for miceSurvivin and Piperine shows good inhibitory interaction effect and can, therefore, be considered as a molecule against Survivin enhanced tumor condition including NB.
Computational docking minimizes the time consuming process of molecular analyses for selecting a suitable ligand which could be then applied for wet lab investigations.[1] Wickbery and Co-workers used Bioinformatics to narrow down suitable ligands for biomedical research and drug design as structure based design shows precisely the location and orientation of bound inhibitors and their physico-chemical properties.[2]
Survivin is an apoptosis pathway inhibitor protein. It has important roles in cell cycle and cell proliferation. In normal embryonic development, expression of Survivin was found to be high and it was also expressed in some adult’s colonic epithelium, uterine, vascular endothelium and subventricular region of brain. In cancer cells, Survivin expression was found to be very high.[3-6] Previous works reported that Survivin mainly works as an inhibitor of apoptosis, blocking mitochondrial dependent apoptosis[7,8] (Figure 1). It was also reported later that it has other role as a mitotic checkpoint.[9]
Survivin family of proteins are involved in control of mitosis and makes perfect cell division in normal cells.[10] It prevents the aneuploidy which normally occurs in malignant tissues.[11]
Fig. 1:
Survivin Pathway.
Neuroblastoma (NB) is a childhood cancer causing significant mortality of at least 1% of children worldwide. Survivin is known to be expressed at high levels in NB.[12]
Piperine is a heterocyclic alkaloid that belongs to a family of nitrogenous compounds with marked physiological properties. It is non-genotoxic, but found to have anti-mutagenic and anti-tumor activity.[13]
Methods
The current study was focused towards developing understanding of Survivin, which has been reported to be up regulated in NB and in certain other tumors.[14] The PDB file of the protein was downloaded from RCSB (www.rcsb.org) which was then purified in a docking server. In the same server docking calculation were carried out. Also the ligand piperine, an alkaloid was drawn using ChemDraw tool v.4.0 and converted to PDB file format using MGL tool. The target protein and the ligand were subjected to docking.Essential hydrogen atoms, Kollman united atom type charges, and salvation parameters were added with the aid of auto dock tools. The affinity (grid) map of XXÅ mid points 0.375Å spacing was generated using the autogrid program.[15] Auto dock parameters were set on distance dependent dielectric Van-der-waals and the electro static terms respectively.Docking simulations were performed using the Lamarckian Genetic Algorithm (LGA) and the Solis and Wets local search method.[16] Initial position, orientation and torsions of the ligand molecules were set randomly. All rotatable torsions were released during docking. Each docking experiment was derived from two different runs that were set to terminate after maximum of 25000 energy evaluations. The population size was set at 150. During the search, a translational step of 0.2Å and quaternion step of 5 were applied.[17]Survivin Pathway.
Results
Molecule docking of Survivin with ligand Piperine has an outcome of good energy level calculations that suit drug modeling of the ligand (Figure 2). Free energy (ΔG) of –3.36 Kcal/mol, inhibition constant (Ki) of 3.42 mM, and electrostatic energy of –0.04 Kcal/mol (Table 1) was noted.
Fig. 2:
Binding conformation of survivin and piperine.
Table 1:
Molecular docking energy level table
Result Table
Rank
Est. Free Energy of Binding
Est. Inhibition Constant, Ki
vdW + Hbond + desolv Energy
Electrostatic Energy
Total Intermolec. Engergy
Frequency
Interact. Surface
Download
1
–3.36 kcal/mol
3.42 mM
–4.15 kcal/mol
–0.04 kcal/mol
–4.19 kcal/mol
50%
512.417
download
2
–3.09 kcal/mol
5.39 mM
–4.09 kcal/mol
–0.11 kcal/mol
–3.97 kcal/mol
50%
512.053
download
The protein–ligand interaction study showed 6 amino acid residues interaction with the ligand (12:Leu, 20:Ala, 21:Thr, 44:Ile, 46:Cys, 56:Gln) (Table 2). The interaction of ligand and protein was generated and is depicted in HB plot (Figure 3).
Table 2:
Protein and ligand interaction table of residues and atoms
Interaction Table
Hydrogen bonds
Hydrophobic
Other
N1 0 GLN56 –[3.02] (OE1)
C12 0 LEU12 –[3.20] (CD2)
O1 0 ALA20 – [3.43] (CB)
C13 0 LEU12 –[3.56] (CD2)
C15 THR21 –[3.44] (CB,CG,OG1)
C17 0 ALA20 –[3.70] (CB)
C11 0 THR21 –[3.70] (CG2,OG1)
C7 0 ILE44 –[3.18] (CD1)
C12 0 THR21 –[3.57] (OG1)
C6 0 ILE44 –[3.77] (CD1)
C13 0 THR21 –[3.42] (OG1)
C5 0 ILE44 –[3.59] (XD1)
C14 0 THR21 –[3.33] (OG1)
C1 0 CYS46 –[3.43] (CB,SG)
C16 0 THR21 –[3.38] (CG2,OG1)
C3 0 GLN56 –[3.15] (CD,OE1)
C6 0 GLN56 –[3.87] (eG1)
C4 0 GLN56 –[2.38] (OE1)
C5 0 GLN56 –[3.04] (OE1)
C1 0 GLN56 –[3.04] (OE1)
Fig. 3:
Interaction of ligand and protein in HB plot.
Discussion
NB is a hidden health risk for both the public and the researchers. Therefore, a drug that can inhibit the disorder will be helpful in better health management.The signaling cascade molecules in NB need to be analyzed computationally for better ligand. For this purpose molecular docking is an ideal tool.[18] Faster and cheaper methods for drug designing at initial stages include molecular docking. In this study, the simulation of protein–ligand chemistry, binding and dissociation energy were focused upon. The energy and interaction details have been developed using Auto Dock. The free energy (ΔG) of interaction is –3.36 Kcal/mol, which is in good agreement with physiological protein-ligand (hormones, enzymes) interaction range of –2.00 Kcal/mol to –6.00 Kcal/mol[19] therefore; our result suggests a good candidate for protein–ligand interaction.Binding conformation of survivin and piperine.Inhibition constant (Ki) is an important force in molecular interaction. Obtained Ki[20] is favorable towards developing a novel drug molecule. Vander Waal’s force, hydrogen bonds are the other factors which stabilize ligand-protein interaction in our docking study, in which the results for electrostatic force of molecules were significantly less, and it is a sign of a good protein-drug interaction. Docking results give binding site analysis for 6 amino acids, with the ligand which shows precise conformity. Three polar residues and 3 non-polar residues reflect a stable electrostatic interaction. Even though there is a single H-bond, the electrostatic force obtained in the result is significant enough for a strong bonding in case of a protein-drug interaction.[21] Also, the existence of rich number of ionic bond in the docking study suffices for a further more stable association. The ligand Piperine interacted well with the protein Survivin in the docking grid.Interaction of ligand and protein in HB plot.
Conclusions
Molecular docking of surviving (mice) with ligand Piperine when subjected to docking analysis using AutoDock and docking server, predicted in-silico result with a free energy of –3.36 Kcal/mol which was agreed well with physiological range for protein-ligand interaction, making Piperine probable potent anti-survivin molecule. Therefore, it is expected that Piperine might participate by down regulating the levels of Survivin upon administration, making the NB cells pro-apoptotic, eventually leading to death of tumor cells.
Authors: J R Fangusaro; Y Jiang; M P Holloway; H Caldas; V Singh; D R Boué; J Hayes; R A Altura Journal: Br J Cancer Date: 2005-01-31 Impact factor: 7.640